These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 25620824)
21. Assessment of the prognostic and predictive utility of the Breast Cancer Index (BCI): an NCIC CTG MA.14 study. Sgroi DC; Chapman JA; Badovinac-Crnjevic T; Zarella E; Binns S; Zhang Y; Schnabel CA; Erlander MG; Pritchard KI; Han L; Shepherd LE; Goss PE; Pollak M Breast Cancer Res; 2016 Jan; 18(1):1. PubMed ID: 26728744 [TBL] [Abstract][Full Text] [Related]
22. Twenty-year follow-up of the Royal Marsden randomized, double-blinded tamoxifen breast cancer prevention trial. Powles TJ; Ashley S; Tidy A; Smith IE; Dowsett M J Natl Cancer Inst; 2007 Feb; 99(4):283-90. PubMed ID: 17312305 [TBL] [Abstract][Full Text] [Related]
23. Artificial neural networks estimating survival probability after treatment of choroidal melanoma. Damato B; Eleuteri A; Fisher AC; Coupland SE; Taktak AF Ophthalmology; 2008 Sep; 115(9):1598-607. PubMed ID: 18342942 [TBL] [Abstract][Full Text] [Related]
24. A two-step semiparametric method to accommodate sampling weights in multiple imputation. Zhou H; Elliott MR; Raghunathan TE Biometrics; 2016 Mar; 72(1):242-52. PubMed ID: 26393409 [TBL] [Abstract][Full Text] [Related]
25. Modeling age and nest-specific survival using a hierarchical Bayesian approach. Cao J; He CZ; Suedkamp Wells KM; Millspaugh JJ; Ryan MR Biometrics; 2009 Dec; 65(4):1052-62. PubMed ID: 19302407 [TBL] [Abstract][Full Text] [Related]
26. Kaplan-Meier curves for survivor causal effects with time-to-event outcomes. Chiba Y Clin Trials; 2013 Aug; 10(4):515-21. PubMed ID: 23610455 [TBL] [Abstract][Full Text] [Related]
27. A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis. Hirooka T; Hamada C; Yoshimura I Methods Inf Med; 2009; 48(2):104-12. PubMed ID: 19283306 [TBL] [Abstract][Full Text] [Related]
28. Research participant compensation: A matter of statistical inference as well as ethics. Swanson DM; Betensky RA Contemp Clin Trials; 2015 Nov; 45(Pt B):265-269. PubMed ID: 26334678 [TBL] [Abstract][Full Text] [Related]
29. Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group. Rutqvist LE; Mattsson A J Natl Cancer Inst; 1993 Sep; 85(17):1398-406. PubMed ID: 8350363 [TBL] [Abstract][Full Text] [Related]
30. [Meta-analysis of the Italian studies on short-term effects of air pollution]. Biggeri A; Bellini P; Terracini B; Epidemiol Prev; 2001; 25(2 Suppl):1-71. PubMed ID: 11515188 [TBL] [Abstract][Full Text] [Related]
32. A semiparametric approach for the nonparametric transformation survival model with multiple covariates. Song X; Ma S; Huang J; Zhou XH Biostatistics; 2007 Apr; 8(2):197-211. PubMed ID: 16670240 [TBL] [Abstract][Full Text] [Related]
33. On a Shape-Invariant Hazard Regression Model with application to an HIV Prevention Study of Mother-to-Child Transmission. Zheng C; Chen YQ Stat Biosci; 2020 Dec; 12(3):340-352. PubMed ID: 33312265 [TBL] [Abstract][Full Text] [Related]
34. Prognostic impact of second cancer on the survival of early breast cancer patients. Nomura Y; Tsutsui S; Murakami S; Takenaka Y Int J Oncol; 1999 Jun; 14(6):1103-9. PubMed ID: 10339665 [TBL] [Abstract][Full Text] [Related]
35. Landmark Estimation of Survival and Treatment Effect in a Randomized Clinical Trial. Parast L; Tian L; Cai T J Am Stat Assoc; 2014 Jan; 109(505):384-394. PubMed ID: 24659838 [TBL] [Abstract][Full Text] [Related]
36. Assessment and statistical modeling of the relationship between remotely sensed aerosol optical depth and PM2.5 in the eastern United States. Paciorek CJ; Liu Y; Res Rep Health Eff Inst; 2012 May; (167):5-83; discussion 85-91. PubMed ID: 22838153 [TBL] [Abstract][Full Text] [Related]
37. Use of posterior predictive checks as an inferential tool for investigating individual heterogeneity in animal population vital rates. Chambert T; Rotella JJ; Higgs MD Ecol Evol; 2014 Apr; 4(8):1389-97. PubMed ID: 24834335 [TBL] [Abstract][Full Text] [Related]
38. Anastrozole versus tamoxifen as adjuvant therapy for Japanese postmenopausal patients with hormone-responsive breast cancer: efficacy results of long-term follow-up data from the N-SAS BC 03 trial. Aihara T; Yokota I; Hozumi Y; Aogi K; Iwata H; Tamura M; Fukuuchi A; Makino H; Kim R; Andoh M; Tsugawa K; Ohno S; Yamaguchi T; Ohashi Y; Watanabe T; Takatsuka Y; Mukai H Breast Cancer Res Treat; 2014 Nov; 148(2):337-43. PubMed ID: 25318924 [TBL] [Abstract][Full Text] [Related]
39. Regression models for the restricted residual mean life for right-censored and left-truncated data. Cortese G; Holmboe SA; Scheike TH Stat Med; 2017 May; 36(11):1803-1822. PubMed ID: 28106926 [TBL] [Abstract][Full Text] [Related]
40. Surgery versus primary endocrine therapy for operable primary breast cancer in elderly women (70 years plus). Hind D; Wyld L; Beverley CB; Reed MW Cochrane Database Syst Rev; 2006 Jan; (1):CD004272. PubMed ID: 16437480 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]